HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.6

Change

-0.03 (-0.35)%

Market Cap

N/A

Volume

1.65K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.05 (-0.14%)

CAD 6.64B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.27 (-0.97%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.91B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.16 (-0.42%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.24 (-0.51%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.05 (-0.19%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.12 (+1.11%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.13% 89% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.13% 89% A- 80% B-
Trailing 12 Months  
Capital Gain -2.27% 7% C- 16% F
Dividend Return 3.99% 74% C 62% D
Total Return 1.72% 9% A- 17% F
Trailing 5 Years  
Capital Gain 5.26% 33% F 43% F
Dividend Return 38.55% 95% A 93% A
Total Return 43.82% 63% D 58% F
Average Annual (5 Year Horizon)  
Capital Gain 3.57% 52% F 45% F
Dividend Return 4.31% 53% F 42% F
Total Return 0.74% 81% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.29% 68% D+ 84% B
Risk Adjusted Return 59.10% 71% C- 68% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike